Author

Clémentine Halliez

Centre National de la Recherche ScientifiqueORCID 0000-0002-5683-515XUnclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Molecular Biology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Assay:bulk RNA-seq· 1 Research Focus:cell type annotation· 1 Research Focus:differential expression· 1 Approach:experimental assay· 1 Organism:human· 1

Frequent Co-Authors

Decio Laks EizirikiD· 1 shared Diego BalboaiD· 1 shared Federica VecchioiD· 1 shared Hazem IbrahimiD· 1 shared Hossam MontaseriD· 1 shared Isabella ArtneriD· 1 shared Jonna Saarimäki‐VireiD· 1 shared Jouni KvistiD· 1 shared

Activity by Year

2022-2022 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperMolecular Biology

Decio Laks EizirikORCID

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

The type 1 diabetes gene TYK2 regulates β-cell development and its responses to interferon-α

Vikash Chandra, Hazem Ibrahim, Clémentine Halliez, Rashmi B. Prasad, Federica Vecchio, Om Prakash Dwivedi, Jouni Kvist, Diego Balboa, Jonna Saarimäki‐Vire, Hossam Montaser, Tom Barsby, Väinö Lithovius, Isabella Artner, Swetha Gopalakrishnan, Leif Groop, , Timo Otonkoski

This study shows that TYK2 is critical for β-cell development by regulating KRAS and IFN responses, suggesting TYK2 inhibition as a therapeutic target for type 1 diabetes.

Nature Communications · Oct 26, 2022Peer-reviewedMolecular Biology